Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A systematic review and meta‐analysis

Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A systematic review and meta‐analysis

Abstract Background Currently, immune checkpoint blockers (ICB) and radiotherapy (RT) combination therapy is broadly applied in non‐small cell lung cancer (NSCLC) patients. However, meta‐analysis about safety and efficacy of RT + ICB versus ICB has not yet been reported. To evaluate safety and effic...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Yichun Zeng, Liying Zhang, Yichen Liang, Xian Zhang, Lei Li, Maoqi Wang, Jingliang Guo, Qiuxian Li, Jin Cao, Juan J. Gu, Buhai Wang
Materialtyp: Artikel
Språk:English
Publicerad: Wiley 2023-07-01
Serie:Cancer Medicine
Ämnen:
combination therapy
immune checkpoint blockers
meta‐analysis
non‐small cell lung cancer
radiotherapy
Länkar:https://doi.org/10.1002/cam4.5958

Internet

https://doi.org/10.1002/cam4.5958

Liknande verk